EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C29H30O8 |
| Net Charge | 0 |
| Average Mass | 506.551 |
| Monoisotopic Mass | 506.19407 |
| SMILES | [H][C@@]1(c2ccc(OC)cc2OCCO)c2cc(OCCC)ccc2[C@]([H])(c2ccc3c(c2)OCO3)[C@@]1([H])C(=O)O |
| InChI | InChI=1S/C29H30O8/c1-3-11-34-19-6-7-20-22(14-19)27(21-8-5-18(33-2)15-24(21)35-12-10-30)28(29(31)32)26(20)17-4-9-23-25(13-17)37-16-36-23/h4-9,13-15,26-28,30H,3,10-12,16H2,1-2H3,(H,31,32)/t26-,27+,28+/m0/s1 |
| InChIKey | GLCKXJLCYIJMRB-UPRLRBBYSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Biological Role: | endothelin receptor antagonist A hormone antagonist that blocks endothelin receptors. |
| Applications: | endothelin receptor antagonist A hormone antagonist that blocks endothelin receptors. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| enrasentan (CHEBI:156258) has role antihypertensive agent (CHEBI:35674) |
| enrasentan (CHEBI:156258) has role endothelin receptor antagonist (CHEBI:51451) |
| enrasentan (CHEBI:156258) is a aromatic ether (CHEBI:35618) |
| enrasentan (CHEBI:156258) is a benzodioxoles (CHEBI:38298) |
| enrasentan (CHEBI:156258) is a indanes (CHEBI:46940) |
| enrasentan (CHEBI:156258) is a monocarboxylic acid (CHEBI:25384) |
| enrasentan (CHEBI:156258) is a monomethoxybenzene (CHEBI:25235) |
| enrasentan (CHEBI:156258) is a primary alcohol (CHEBI:15734) |
| IUPAC Name |
|---|
| (1S,2R,3S)-1-(1,3-benzodioxol-5-yl)-3-[2-(2-hydroxyethoxy)-4-methoxyphenyl]-5-propoxy-2,3-dihydro-1H-indene-2-carboxylic acid |
| INNs | Source |
|---|---|
| enrasentan | WHO MedNet |
| enrasentan | WHO MedNet |
| enrasentanum | WHO MedNet |
| enrasentán | ChemIDplus |
| Synonyms | Source |
|---|---|
| (1S,2R,3S)-3-(2-(2-hydroxyethoxy)-4-methoxyphenyl)-1-(3,4-(methylenedioxy)phenyl)-5-propoxy-2-indancarboxylic acid | ChemIDplus |
| SB-217242 | ChemIDplus |
| SB217242 | ChEBI |
| SB 217242 | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| DB06460 | DrugBank |
| Registry Numbers | Sources |
|---|---|
| CAS:167256-08-8 | ChemIDplus |
| Citations |
|---|